Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
adult, aggressive, analyzed, ASC, ASCO, atrophy, AUC, auditor, BPF, Bulletin, Cardinal, children, chose, chosen, correlative, disability, dissolve, Dyspnea, eating, edaravone, emotional, error, fraction, GBM, glioblastoma, hazard, highest, Hoffman, Hour, hr, interpretation, lessor, lethal, malignancy, malignant, mandatory, mobility, modest, modified, MRI, nearby, neuroimaging, neurosurgery, noncurrent, Oncology, Oregon, Organization, parenchymal, PCAOB, physical, provisional, quantitative, Questionnaire, radiation, Radicava, ratio, reassessed, remeasurement, repatriation, respond, SAB, Sublocade, taxation, temozolomide, TMZ, Univ, William
Filing tables
Filing exhibits
MNOV similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
MediciNova, Inc.
La Jolla, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-220593, 333-214830 and 333-208274) and Form S-8 (Nos. 333-219491, 333-190490, 333-151808, 333-141694 and 333-122665) of MediciNova, Inc. of our reports dated February 13, 2018, relating to the consolidated financial statements and the effectiveness of MediciNova, Inc.’s internal control over financial reporting, which appear in this Form 10-K.
/s/ BDO USA, LLP
San Diego, California
February 13, 2018